For the quarter ending 2025-09-30, LIPO has $2,349,810 in assets. $862,215 in debts. $1,855,771 in cash and cash equivalents.
| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Grants receivable | - | 41,982 | ||
| Cash and cash equivalents | 1,855,771 | 2,781,828 | ||
| Prepaid expenses | 223,517 | 613,437 | ||
| Total current assets | 2,079,288 | 3,437,246 | ||
| Furniture, fixtures and equipment | 140,294 | 140,294 | ||
| Furniture, fixtures and equipment (accumulated depreciation) | 132,595 | 131,873 | ||
| Furniture and fixtures, net | 7,699 | 8,420 | ||
| Operating lease right of use asset | 262,823 | 274,539 | ||
| Total assets | 2,349,810 | 3,720,206 | ||
| Accounts payable | 462,892 | 608,110 | ||
| Accrued expenses | 34,938 | 15,087 | ||
| Operating lease liability | 44,267 | 42,903 | ||
| Payroll liability | 100,302 | 80,798 | ||
| Total current liabilities | 642,399 | 746,898 | ||
| Operating lease liability, net of current portion | 219,816 | 231,636 | ||
| Total liabilities | 862,215 | 978,534 | ||
| Preferred stock, value-Series BPreferred Stock | 1 | 1 | ||
| Preferred stock, value-Series CPreferred Stock | 0 | 15 | ||
| Common stock, 0.0001 par value per share, 200,000,000 shares authorized, 4,620,837 shares issued and outstanding at september 30, 2025 and 1,208,919 shares issued and outstanding at december 31, 2024 | 462 | 446 | ||
| Additional paid-in capital | 20,715,326 | 20,715,326 | ||
| Accumulated deficit | -19,228,194 | -17,974,116 | ||
| Total stockholders equity | 1,487,595 | 2,741,672 | ||
| Total liabilities and stockholders equity | 2,349,810 | 3,720,206 | ||
LIPELLA PHARMACEUTICALS INC. (LIPO)
LIPELLA PHARMACEUTICALS INC. (LIPO)